HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China

Journal of Diabetes

Volumn 5, Issue 3, 2013, Pages 282-290

  Wu, Shengli ^a   Yi, Fengshou ^a   Zhou, Chao ^b   Zhang, Mintao ^a   Zhu, Yujing ^a   Tuniyazi, Yilihamu ^a   Huang, Lijuan ^a   Huang, Xuefang ^a   Wang, Fugang ^a   Bi, Yufang ^c,d   Ning, Guang ^c,d  

^a Karamay People's Hospital   (China)

^b The Community Medical Service Center   (China)

^c Shanghai Institute of Endocrine and Metabolic Diseases   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; HbA1c threshold; Prediabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUCOSE OXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

DIABETES; HBA1C THRESHOLD; PREDIABETES;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GEOGRAPHY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; ROC CURVE;

EID: 84881542281     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12035     Document Type: Article

References (31)

1. Wild S, Roglic G, Green A etal. Global prevalence of diabetes: Estimates for the Year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-1053.
2. Yang W, Lu J, Weng J etal. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101.
3. Harris MI, Klein R, Welborn TA etal. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992; 15: 815-819.
4. Saudek CD, Herman WH, Sacks DB etal. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008; 93: 2447-2453.
5. Jia WP, Pang C, Chen L etal. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: The Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia. 2007; 50: 286-292.
6. Knowler WC, Barrett-Connor E, Fowler SE etal. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.
7. Gerstein HC, Yusuf S, Bosch J etal. DREAM (Diabetes Reduction Eduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial [published erratum appears in Lancet 2006; 368: 1770]. Lancet. 2006; 368: 1096-1105.
8. Tuomilehto J, Lindström J, Eriksson JG etal. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344: 1343-1350.
9. American Diabetes Association. Standards of medical care in diabetes: 2009. Diabetes Care. 2009; 32 (Suppl. 1): S13-S16.
10. Rohlfing CL, Wiedmeyer HM, Little RR etal. Defining the relationship between plasma glucose and HbA1c: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care. 2002; 25: 275-278.
11. Simon D, Senan C, Garnier P etal. Epidemiological features of glycated hemoglobin A1c distribution in a healthy population: The Telecom Study. Diabetologia. 1989; 32: 864-869.
12. Woerle HJ, Pimenta WP, Meyer C etal. Diagnostic and therapeutic implications of relationships between fasting, 2-hour post challenge plasma glucose and hemoglobin A1c values. Arch Intern Med. 2004; 164: 1627-1632.
13. Barr RG, Nathan DM, Meigs JB etal. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med. 2002; 137: 263-272.
14. Rohlfing C, Wiedmeyer HM, Little R etal. Biological variation of glycohemoglobin. Clin Chem. 2002; 48: 1116-1118.
15. Nathan DM, Balkau B, Bonora E etal. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32: 1327-1334.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus [published erratum appears in Diabetes Care 2010; 33: e57]. Diabetes Care. 2010; 33 (Suppl. 1): S62-S69.
17. Herman WH, Ma Y, Uwaifo G etal. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007; 30: 2453-2457.
18. Bao Y, Ma X, Li H etal. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: Cross sectional epidemiological survey. BMJ. 2010; 340: c2249.
19. Ma YC, Zuo L, Chen JH etal. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17: 2937-2944.
20. World Health Organization (WHO). Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of WHO Consultation. WHO, Geneva, 1999.
21. Youden WJ. Index for rating diagnostic tests. Cancer. 1950; 3: 32-35.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988; 44: 837-845.
23. Selvin E, Crainiceanu CM, Brancati FL etal. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med. 2007; 167: 1545-1551.
24. Miedema K. Towards worldwide standardization of HbA1c determination. Diabetologia. 2004; 47: 1143-1148.
25. Nakagami T, Tominaga M, Nishimura R etal. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract. 2007; 76: 251-256.
26. Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of type 2 diabetes: A systematic review. Diabet Med. 2007; 24: 333-343.
27. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care. 2007; 30: 2233-2235.
28. Colagiuri S, Lee CM, Wong TY etal. Glycemic thresholds for diabetes specific retinopathy: Implications for diagnostic criteria for diabetes [published erratum appears in Diabetes Care 2011; 34: 1888]. Diabetes Care. 2011; 34: 145-150.
29. Yang ZJ, Yang WY, Li GW. National Diabetes Prevention and Control Cooperative Group. The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population. Zhonghua Yi Xue Za Zhi. 2003; 83: 2128-2131. (in Chinese).
30. Qiao Q, Nakagami T, Tuomilehto J etal. Comparison of the fasting and the 2h glucose criteria for diabetes in different Asian cohorts. Diabetologia. 2000; 43: 1470-1475.
31. Pani LN, Korenda L, Meigs JB etal. Effects of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care. 2008; 31: 1991-1996.